NEW MEMBER SIGN UP
  Display Name
 
  Email Address
 
  Password
 
  Password again
 
  Zip
 
Country
 
   

Close Window

Privacy Statement
BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
     
Community Login

What is this?
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel Employers
 Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Purdue Pharmaceuticals L.P. 

4701 Purdue Drive

Wilson  North Carolina  27893  U.S.A.
Phone: 252-265-1900 Fax: 252-243-2533


SEARCH JOBS

Purdue Pharmaceuticals L.P. is a 240,000 square foot, state-of-the-art pharmaceutical manufacturing and packaging plant that produces tablets and capsules in bottle and blister trade pack configurations for Purdue Pharma L.P., an independent associated company headquartered in Stamford, CT. These privately held companies, founded by physicians and focused on meeting the needs of healthcare providers and the patients in their care, are dedicated to finding, developing, and bringing to market new medicines and related products that improve health outcomes. The companies have long been known for their pioneering research on persistent pain, a principal cause of human suffering.

Purdue also has growing line of non-prescription products including laxatives, microbicides, and nutraceuticals. The company is dedicated to serving the evolving needs of healthcare providers, patients, and caregivers with innovative prescription and non-prescription medicines. A commitment to innovation and caring spans every aspect of the organization, from discovering and launching new medicines to demonstrating their medical value.

Purdue has led the battle against inadequate treatment of pain by developing sustained-release medications to manage pain and provide meaningful benefits for patients. Its sales, marketing, and medical education professionals provide the healthcare community with comprehensive educational materials and programs relating to pain management.

In 1993, Purdue established Partners Against Pain® as a resource to help patients, caregivers, and healthcare professionals advance standards of pain care and alleviate unnecessary suffering through education and advocacy. Purdue has also assumed a leading role in addressing the serious public health problem of prescription drug abuse, supporting programs intended to help stem abuse.

At its research facilities in Cranbury, New Jersey, Purdue scientists are discovering new compounds to treat pain and developing innovative formulations and delivery systems that improve patient compliance and safety and have tamper-resistant properties, while still providing safe and effective pain control.

Last Updated: 03-17-2008

 Key Statistics


Email:
Ownership:
Web Site: Purdue Pharmaceuticals L.P.
Employees: 150
Symbol: 
 



Industry
Pharmaceutical






 Company News
NASCSA Receives $200,000 Grant From Purdue Pharmaceuticals L.P. to Support State Prescription Drug Monitoring Programs Additional Funding to Help Prevent Abuse and Diversion of Medications 10/21/2009 9:33:36 AM    More...
Transcept Pharmaceuticals, Inc. Inks $145 Million Sleep Drug Deal with Purdue Pharmaceutical Products LP 8/4/2009 7:04:36 AM    More...
KV Pharmaceutical Company (KV-A), Purdue Pharmaceuticals L.P. Settle OxyContin(R) Dispute 6/10/2009 10:38:13 AM    More...
Infinity Pharmaceuticals, Inc. Announces Completion of Second Equity Investment by Purdue Pharmaceuticals L.P. 1/8/2009 8:32:39 AM    More...
Infinity Pharmaceuticals, Inc. Announces Global Strategic Alliance With Purdue Pharmaceuticals L.P. and Mundipharma International Limited Encompassing Infinity's Early Clinical and Discovery Programs; Infinity to Receive Up to $75M Equity Investment, Access to $50M Line of Credit, and Significant R&D Funding Over Multiple Years 11/20/2008 8:50:59 AM    More...
Covidien Ltd Announces Agreement with Purdue Pharmaceuticals L.P. Enabling Launch of Oxycodone Hydrochloride Extended-Release Tablets 9/2/2008 9:07:52 AM    More...
Purdue Pharmaceuticals L.P. Announces Resolution of OxyContin(R) Patent Lawsuit with Mallinckrodt Inc. 9/2/2008 7:49:19 AM    More...
Oxycontin That's Harder To Abuse? FDA Debates Purdue Pharmaceuticals L.P.'s New Version 5/2/2008 1:48:37 AM    More...
IMPAX Laboratories, Inc. (IPXL) to Resume Limited Sales of Extended Release Oxycodone Under License from Purdue Pharmaceuticals L.P. 11/27/2007 10:17:53 AM    More...
Purdue Pharmaceuticals L.P. Selects Systech to Provide Sustainable Infrastructure for Serialization 9/10/2007 11:06:16 AM    More...
123